Literature DB >> 20634383

Go long! A touchdown for factor VIII?

Steven W Pipe1.   

Abstract

Year:  2010        PMID： 20634383     DOI： 10.1182/blood-2010-03-274233

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Pharmacokinetic-guided dosing of factor VIII concentrate in a patient with haemophilia during renal transplantation.

Authors:  Hendrika C A M Hazendonk; Marieke J H A Kruip; Ron A A Mathôt; Marjon H Cnossen
Journal:  BMJ Case Rep       Date:  2016-09-22

2.  Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.

Authors:  T E Coyle; M T Reding; J C Lin; L A Michaels; A Shah; J Powell
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

3.  Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.

Authors:  Keri Csencsits-Smith; Krill Grushin; Svetla Stoilova-McPhie
Journal:  J Blood Disord Transfus       Date:  2015-12-18

4.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.